Surrozen, Inc. Overview
SRZN market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
SRZN price chart · 1M
- O
- 31.34
- H
- 31.34
- L
- 28.94
- C
- 29.00
- Vol
- 10,483.00
Daily history from Jan 12, 2021
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $31.34
- Previous Close
- $31.64
- Day High
- $31.34
- Day Low
- $28.94
- 52 Week High
- $37.23
- 52 Week Low
- $11.85
- 7 Day Return
- -1.46%
- 30 Day Return
- +10.35%
- 90 Day Return
- +14.31%
- 1 Year Return
- +140.17%
- Daily Notional Volume
- $304K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$32.37 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.64 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -2,885.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $11.39 – $37.83 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $340.9M · P/B 0.51 · P/S 29.61.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured